10.6084/M9.FIGSHARE.13174391.V1
Qi Wang
Qi
Wang
Xiaotao Zhao
Xiaotao
Zhao
Zhihong Yue
Zhihong
Yue
Xiaohui Bai
Xiaohui
Bai
Huiying Rao
Huiying
Rao
Na Han
Na
Han
Tianbing Wang
Tianbing
Wang
Hui Wang
Hui
Wang
Baoguo Jiang
Baoguo
Jiang
Increasing SARS-CoV-2 nucleic acid testing capacity during the COVID-19 epidemic in Beijing: experience from a general hospital
<p>Under the ongoing COVID-19 prevention and control measures in China, increasing the laboratory severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid testing capacity has become the top priority. Since the COVID-19 outbreak in Xinfadi market in Beijing in June 2020, large-scale screening of key populations has been carried out, challenging the nucleic acid testing capabilities of hospital laboratories. Therefore, within 48 hours, Peking University People’s Hospital (PKUPH) transformed a non-nucleic acid testing laboratory into a SARS-CoV-2 nucleic acid testing laboratory. Based on the original structure of the building, we adapted measures to local conditions, sorted out a new testing process, and quickly started testing for COVID-19. The nucleic acid testing process has been optimized, including quality control, personal operating specifications, and the timeliness of the release of LIS results to form closed-loop management. This high-throughput COVID-19 testing optimization process provides a reference model for other countries that are fighting the epidemic.</p>
Medicine
Molecular Biology
Evolutionary Biology
Immunology
Biological Sciences not elsewhere classified
Infectious Diseases
Computational Biology
Taylor & Francis
2020
2020-11-01
2024-02-07
Journal contribution
164107 Bytes
10.6084/m9.figshare.13174391
10.1080/22221751.2020.1837016
CC BY 4.0